HARONGA HARUNGANA MADAGASCARIENSIS LAM

HARONGA (Harungana madagascariensis Lam. ex Poir.) +

Synonym:
Haronga madagascariensis Choisy.

Activities (Haronga) :
Antipyretic (f; UPW); Antiseptic (2; PHR; PH2); Antitussive (f; UPW); Antiviral (1; FNF; HAD); Aphrodisiac (f; UPW); Cholecystokinetic (2; KOM); Choleretic (2; HHB; KOM; PH2); Ecbolic (f; UPW); Emetic (1; FNF; HAD); Expectorant (f; UPW); Fungicide (1; FNF; HAD); Gastrotonic (2; KOM; PH2); Hepatoprotective (1; PHR; PH2); Laxative (1; FNF; HAD; UPW); Mastogenic (f; WBB); Pancreatonic (2; KOM); Rubefacient (f; WBB); Secretagogue (2; HHB; KOM); Vermifuge (f; UPW).

Indications (Haronga) :
Amenorrhea (f; UPW); Anorexia (2; PHR); Asthma (f; UPW); Bleeding (1; WBB); Bronchosis (f; UPW); Cardiopathy (f; UPW); Childbirth (f; WBB); Cholecystosis (2; PHR; PH2); Colic (f; WBB); Constipation (1; FNF; HAD; PH2; UPW); Cough (f; UPW); Craw-craw (f; UPW); Dermatosis (f; HHB); Diarrhea (1; PH2; WBB); Dysentery (f; UPW); Dysmenorrhea (f; UPW); Dyspepsia (2; KOM); Dyspnea (f; UPW); Edema (f; UPW); Enterosis (f; UPW); Fever (f; UPW; WBB); Fungus (1; FNF; HAD); Ganglosis (f; UPW); Gas (f; UPW); Gastrosis (f; UPW); Gonorrhea (f; WBB); Hematuria (f; UPW); Hemorrhoid (f; UPW); Hepatosis (2; PHR; PH2; UPW); Infection (1; FNF; HAD; WBB); Itch (f; UPW); Jaundice (f; UPW); Leprosy (f; UPW); Malaria (f; UPW); Mange (f; UPW); Micromastia (f; WBB); Miscarriage (f; UPW); Mycosis (1; FNF; HAD; UPW); Pancreatic Insufficiency (2; HHB; KOM); Pancreatosis (2; HHB; KOM); Prickly Heat (f; UPW);
Pulmonosis (f; UPW); Ringworm (1; FNF; HAD; UPW); Roundworm (f; WBB); Scabies (f; UPW; WBB); Sore (f; UPW); Sore Throat (f; WBB); Staphylococcus (1; UPW); Stomachache (f; UPW); Toothache (f; UPW); Ulcer (f; UPW); Urethrosis (f; UPW); VD (f; WBB); Virus (1; FNF; HAD); Worm (f; UPW); Wound (f; UPW).

Dosage (Haronga) :
7.5 - 15 mg hydroalcoholic extract (dry) corresponding to 25 - 50 mg drug (PH2).

Contraindications, Interactions, and Side Effects (Haronga) :
Not covered (AHP). Hazards and/or side effects not recorded for proper therapeutic dosages (PH2). Commission E reports contraindications of bark with leaf: acute pancreatitis (though recommended for pancreatic insufficiency), severe hepatic dysfunction, bile stones, biliary obstruction, empyema of gall bladder, ileus; adverse effects: photosensitivity remotely possible due to hypericin and pseudohypericin.
Should not be used for more than 2 months (AEH; KOM; PHR; PH2).